Tisotumab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Tisotumab Usage And Synthesis

Uses

Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody and ADC antibody. Tisotumab targets tissue factor (TF). Tisotumab can be used for the research of solid tumors[1].

in vivo

References

[1] Coleman RL, et al. Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. Lancet Oncol. 2021 May;22(5):609-619. DOI:10.1016/S1470-2045(21)00056-5
[2] Takao S, et al. Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies. Cancer Immunol Immunother. 2025 Jan 3;74(2):48. DOI:10.1007/s00262-024-03903-2

Tisotumab(1418628-81-5)Related Product Information

• Lemzoparlimab
• Trastuzumab
• Exbivirumab
• Research Grade Tacatuzumab (DHC01501)
• Tovetumab
• Theralizumab
• Sirukumab
• Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
• Research Grade Sofituzumab(DHJ31004)
• Anifrolumab